G.R. No. 1164 - Aldeguer vs. Hoskyn

Case Summary (G.R. No. 1164)

Re-allocation of responsibilities and incentive scheme revision

By April 2002 Galderma formally modified Gan’s incentive program to reflect the addition of Locetar and Benzac to his responsibilities. The revised mechanics redistributed monthly, YTD and annual incentives among Cetaphil, Locetar, and Benzac (reducing the Cetaphil portion but preserving overall opportunity to earn the same aggregate amount if targets for the three brands were met). The December 14, 2001 correspondence had earlier notified employees that management reserved the prerogative to modify or cancel incentive programs with 30-day advance notice.

Events leading to the resignation

Petitioner recounts repeated confrontations with Veneracion between March and April 2002, which he characterizes as harassment — including criticisms of his work, requests that he reconsider his stay, reassignment to report to a different manager, and an offer to be given 15 days to look for another job (which Gan alleges effectively terminated him). Gan alleges that on April 11, 2002 Veneracion proposed that Gan tender a voluntary resignation effective July 15, 2002 in exchange for continued pay and benefits until that date (a “90-day pay sweetener”), and that Gan was required to submit periodic field reports while being excused from office attendance. Gan thereafter submitted a resignation letter on April 11, 2002 stating an effective date of July 15, 2002 "to pursue the establishment of my own business or explore opportunities with other companies." That resignation was accepted by his immediate superior the same day.

Procedural history

July 25, 2002: Gan filed a complaint for illegal constructive dismissal, backwages, separation pay, damages, attorney’s fees, and costs against Galderma and Veneracion.
April 21, 2003: Labor Arbiter dismissed the complaint for constructive dismissal and ordered payment of the stated final pay (PHP 50,425.02). The Arbiter found Gan’s resignation voluntary and relied on the resignation letter and supporting affidavits from Galderma staff.
NLRC: Affirmed the Labor Arbiter’s decision, finding the resignation voluntary and untainted by coercion or intimidation; emphasized Gan’s managerial status, education and experience.
Court of Appeals: Denied Gan’s petition for certiorari under Rule 65, finding no grave abuse of discretion by the NLRC and adopting its factual findings.
Supreme Court review (petition for review on certiorari under Rule 45): The Supreme Court denied relief, with a single modification regarding entitlement to incentive pay for April 2002.

Issues presented on review

Whether Gan’s resignation was involuntary and therefore a constructive dismissal vitiating his resignation.
Whether the tribunal rulings (Labor Arbiter, NLRC, CA) involved grave abuse of discretion or misapprehension of facts justifying reversal.
Whether respondent Veneracion could be held individually liable for constructive dismissal.

Legal standards applied by the tribunals and the Court

Constructive dismissal: exists when the employer’s acts make continued employment impossible or when there is demotion, diminution of pay or other conditions so unbearable that a reasonable employee would be compelled to resign; the test is whether a reasonable person in the employee’s position would have felt compelled to give up employment.
Resignation: generally a voluntary act; intent to relinquish must concur with overt act; acts before and after resignation are relevant to discern intent.
Burden of proof: where an employee asserts that a written resignation was involuntary, the employee must prove the involuntariness with clear, positive and convincing evidence and with particularity; allegations of coercion/intimidation must satisfy requisites established in St. Michael Academy v. NLRC: (1) intimidation caused the consent; (2) threatened act unjust or unlawful; (3) the threat was real/serious and disproportionate; and (4) the source had the means to inflict threatened injury.
Standard of review in the Supreme Court: factual findings of labor tribunals and the Court of Appeals are accorded great weight and finality when supported by substantial evidence; the Supreme Court will only re-examine facts under limited exceptions (e.g., findings are speculative, manifestly mistaken, based on misapprehension, conflicting, unsupported by citation of evidence, or contradicted by record admissions).

Application of standards to the record and Court’s reasoning

The Supreme Court found no compelling basis to disturb the factual findings of the Labor Arbiter, NLRC and CA. The Court emphasized deference to the specialized fact-finding role of labor tribunals and the CA’s factual determinations under Rule 45, given that Gan’s claims were not shown to fall within the limited exceptions permitting factual reappraisal.
On the question of harassment and intimidation, the Court concluded that the alleged acts were either ambiguous, susceptible to multiple interpretations, or insufficiently corroborated. The remarks attributed to Veneracion (e.g., “reconsider your stay,” “make your move,” that “Galderma will be better off without him”) were regarded as ambivalent and not a firm, demonstrable threat amounting to coercion under the St. Michael test. The Court noted the lack of substantial documentary or testimonial evidence corroborating Gan’s characterization of pervasive coercion, and gave weight to sworn statements by multiple Galderma officers denying coercion.
The revision of the incentive scheme was upheld as a valid exercise of management prerogative because inclusion of new product responsibilities reasonably justified redistribution of incentives; the change did not automatically diminish aggregate earning potential if targets for all assigned brands were met. The Court, however, recognized that the immediate implementation of the revised scheme in April 2002 violated the 30-day notice expectation stated in the December 14, 2001 correspondence, and therefore limited relief was required.

Cour

Case Syllabus (G.R. No. 1164)

Case Caption, Citation and Procedural Posture

Supreme Court, Third Division; G.R. No. 177167; Decision dated January 17, 2013; reported at 701 Phil. 612.
Petition for review on certiorari under Rule 45 of the Rules of Civil Procedure seeking reversal of the Court of Appeals' March 21, 2007 decision in CA-G.R. SP No. 91118.
The Court of Appeals had affirmed the resolutions of the National Labor Relations Commission (NLRC) which, in turn, affirmed the Labor Arbiter’s dismissal of Nelson B. Gan’s complaint for constructive (illegal) dismissal.
The Supreme Court denied the petition but modified the disposition insofar as it ruled that for April 2002 Gan was entitled to the monetary benefits under the original December 14, 2001 2002 incentive scheme; the Labor Arbiter was directed to include the difference in Gan’s final pay.

Parties and Roles

Petitioner: Nelson B. Gan — employed by Galderma Philippines, Inc. as Product Manager for the Consumer Products Division (handling Cetaphil Brand Product Lines) effective March 1, 2001.
Respondents: Galderma Philippines, Inc. (Galderma) — employer and wholly-owned subsidiary of Galderma Pharma S.A.; Rosendo C. Veneracion — President and General Manager of Galderma named as individual respondent.
Immediate supervisors mentioned: Stephen C. Peregrino (initial Sales & Marketing Manager), and, after September 1, 2001, direct reporting to Respondent Veneracion; later involvement of Senior Product Manager Gerry M. Castro.

Employment Terms, Salary and Benefits (as hired March 1, 2001)

Monthly Salary: PHP 30,000.00 with guaranteed 13th month pay.
Sales Incentives Scheme (initial):
- Monthly incentive: PHP 8,000.00 (payable should the monthly sales target for CBPL be achieved);
- Year-to-Date (YTD) incentive: PHP 2,000.00 (for consistent achievement);
- Annual incentive: PHP 15,000.00 (upon attainment of annual sales target).
Other benefits and perquisites:
- Provision and free use of company car; monthly car allowance PHP 3,200.00 (later noted increase);
- Vision care annual subsidy PHP 1,200.00 for Gan and dependents;
- Rice subsidy PHP 1,500 every other month;
- Grocery items worth PHP 900.00 upon attainment of monthly sales target (subject to upgrade);
- Funeral assistance PHP 10,000;
- Monthly cellular reimbursement PHP 500.00;
- Paid vacation leave: ten working days per annum after one year;
- Paid sick leave: ten working days per annum after six months;
- Paid funeral leave: five days for immediate family member death;
- Paternity leave; Group Life Insurance; Group Personal Accident Insurance; Retirement Plan; foreign travel incentive subject to performance.

Performance Record and Recognition (2001–early 2002)

Performance appraisal for 2001: “FULLY EFFECTIVE RATING” overall with top scores in key result areas (Brand Growth, Business Expansion, Profitability, Marketing Plan, Implementation) and high behavioral assessment ratings including a “6 — Exceptionally effective” in Teamwork.
Compensation increases documented:
- 40% increase in gross monthly salary from PHP 30,000.00 to PHP 42,000.00 effective January 1, 2002 (Office Correspondence of December 10, 2001).
- Monthly sales incentive increased from PHP 8,000.00 to PHP 9,000.00 effective January 1, 2002 (Office Correspondence of December 14, 2001).
- Monthly car allowance increase to PHP 4,125.00 (implemented and included in pay, not evidenced by memorandum).
Inclusion among employees entitled to all-expense-paid overseas trip (Sydney, Australia) for 2001; Gan could not join due to visa problem.
First quarter 2002 CBPL performance: markedly improved sales metrics — first quarter net sales nearly double 2000 annual net sales and 53% of 2001 annual net sales; average monthly net sales for 2002 already 96% higher than 2001; commendation by Veneracion for “Good sales results! Looks like we’re off to a good start!! Keep it up!” and “EXCELLENT” comments for PR outputs.

Changes in Duties and Revised Incentive Scheme (2001–April 2002)

December 2001: product-knowledge training provided to Gan on Benzac and Locetar (ethical products) as Galderma intended to give him additional product management responsibilities.
April 2002 revised incentive program, effective April 2002, redistributed incentives among three product lines (Cetaphil consumer line, Locetar, Benzac):
- Monthly incentive split: Cetaphil P4,500; Locetar P3,000; Benzac P1,500 (total monthly incentive distributed among lines, representing a reduction of the allocated share attributable solely to CBPL compared to prior single-line incentive).
- YTD Consistency Award split: Cetaphil P1,000; Locetar P750; Benzac P250.
- Annual incentive split: Cetaphil P7,500; Locetar P5,000; Benzac P2,500.
The December 14, 2001 Office Correspondence had previously advised management’s prerogative to modify or cancel the incentive program subject to the company’s financial capability and promised 30-day advance notice to affected personnel if changes occurred.
Gan admitted that the inclusion of Locetar and Benzac and the change in incentive structure was a valid exercise of management prerogative but later contested implementation timing (30-day notice).

Chronology of Key Events, Gan’s Allegations of Harassment and Constructive Dismissal (March–April 2002)

March 4, 2002: Gan summoned by Veneracion and reproved for taking an emergency sick leave on February 28, 2002 immediately after vacation leave (February 21–27, 2002); objection to Gan texting executive secretary instead of informing Veneracion; Gan apologized.
March 7, 2002: Discussion over Gan’s five-year sales forecast and marketing plan for Benzac; Veneracion questioned Gan’s competence, labeled him “slow, lacking in initiative and uncooperative” and allegedly asked Gan to reconsider his stay or leave — characterized by Gan as the 1st and 2nd acts of harassment.
March 15, 2002 (series of incidents):
- Veneracion requested advertising rates; Gan did not have immediate list and explained reliance on PR agency; Veneracion again criticized Gan as remiss in duties — characterized by Gan as 3rd and 4th acts of harassment.
- Closed-door meeting where Veneracion continued to lambast and allegedly asked Gan again to reconsider staying — 5th act of harassment; Veneracion then ordered Gan to report to Senior Product Manager Gerry M. Castro instead of to Veneracion directly.
April 3, 2002: Meeting with Castro where Gan informed about revision of the 2002 incentive scheme (the 6th act of harassment in Gan’s narrative). The revised scheme reduced Gan’s share from the original single-line incentives; Gan requested one-month transition and non-implementation during transition; he was handed a memorandum dated April 2, 2002 revising the incentive scheme and asked to sign, but Castro agreed he could delay signing.
April 10, 2002: Castro required Gan to put his reconsideration of the revised incentive scheme in writing; Gan complied though he feared further outbursts.
April 11, 2002: Multiple confrontations:
- Veneracion allegedly lambasted Gan for presentation details and indicated inclination to remove CBPL from Gan’s responsibility (7th act of harassment).
- Veneracion allegedly continued to humiliate Gan for submitting request for reconsideration and stated Gan had no right to reject management decisions on compensation and that Gan had become a liability and Galderma would be better off without him (8th act).
- Veneracion allegedly asked whether Gan had sought other employment or consulted a lawyer and again told him to reconsider staying (9th act).
- Veneracion allegedly told Gan he would be given 15 days to look for another job (10th act of harassment), which Gan construed as a de facto termination or a threat of dismissal.
April 11, 2002 — The alleged “forced” negotiation and resignation:
- Gan requested a private meeting with Veneracion; Gan alleges Veneracion offered terms as alternatives to termination in 15 days: (1) require Gan to file voluntary resignation effective July 15, 2002 (90 days); originally 60 days pay was offered but increased to 90 days pay in negotiations; (2) Gan need not report for work starting April 12, 2002 until July 15, 2002; (3) Gan would continue to be paid salary and benefits until July 15, 2002; (4) Gan required to submit periodic field reports twice a month to justify continued payments and to hide agreement from internal auditors.
- Gan asserts he was forced to submit a voluntary resignation that same day to receive the 90-day pay sweetener and that Veneracion dictated reasons to be included in the resignation letter.
Resignation letter dated April 11, 2002 (text included in record): “Please accept my resignation as OTC Product Manager effective July 15, 2002. I am giving the company this notice in advance so that Galderma Philippines may have ample time to find a suitable replacement for my position. I plan to pursue the establishment of my own business or explore opportunities with other companies.” (Signed NELSON GAN).
Castro accepted the resignation on April 11, 2002 by an acceptance memorandum which recognized the three months’ advance notice